home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
The Arsenal Files 6
/
The Arsenal Files 6 (Arsenal Computer).ISO
/
health
/
med9605d.zip
/
M9650946.TXT
< prev
next >
Wrap
Text File
|
1996-03-30
|
3KB
|
46 lines
Document 0946
DOCN M9650946
TI Epstein-Barr virus (EBV) DNA in saliva and EBV serology of
HIV-1-infected persons with and without hairy leukoplakia.
DT 9505
AU Lucht E; Biberfeld P; Linde A; Department of Clinical Virology, Swedish
Institute for Infectious; Disease Control, Stockholm, Sweden.
SO J Infect. 1995 Nov;31(3):189-94. Unique Identifier : AIDSLINE
MED/96163962
AB Secretion of Epstein-Barr virus (EBV) in saliva, as well as serum
antibody titres against various EBV antigens, were analyzed in respect
of (1) 15 HIV-1-infected patients with oral hairy leukoplakia proven to
contain EBV by in situ hybridization, (2) 45 HIV-1 infected patients
without hairy leukoplakia, (3) 10 HIV-1 infected patients treated with
acyclovir or foscarnet and (4) 21 healthy controls. The numbers of CD4+
cells in the peripheral blood were also recorded. The HIV-1 infected
patients were at various stages of HIV-1-associated disease. Excretion
of EBV DNA in the saliva was determined by means of the polymerase chain
reaction (PCR) while the amount of EBV DNA in positive samples was
estimated by repeated titrations. The frequency of shedding of EBV DNA
increased from 33% in healthy controls to 78% in asymptomatic HIV-1
infected persons, but did not increase significantly with progression of
HIV-1-associated disease. The titres of EBV DNA in saliva correlated
inversely and significantly with the number of CD4+ cells in the
peripheral blood. All patients with hairy leukoplakia shed by EBV DNA in
their saliva but the titres were not significantly higher than those of
other HIV-1 infected persons. The serum titres of antibodies against EBV
nuclear antigen 1 (EBNA-1) correlated positively and significantly with
the CD4+ cell count in the peripheral blood. EBNA-1 IgG antibody in the
serum was also significantly lower in symptomatic than in asymptomatic
HIV-1 infected persons. There were, however, no significant differences
in serum antibodies to various EBV antigens between patients with and
without hairy leukoplakia.
DE Acquired Immunodeficiency Syndrome/*COMPLICATIONS/IMMUNOLOGY
Antibodies, Viral/ANALYSIS/IMMUNOLOGY Antigens,
Viral/ANALYSIS/IMMUNOLOGY Comparative Study CD4 Lymphocyte Count DNA,
Viral/*ANALYSIS Enzyme-Linked Immunosorbent Assay Female Herpesvirus
4, Human/IMMUNOLOGY/*ISOLATION & PURIF Human HIV-1/*ISOLATION & PURIF
Leukoplakia, Hairy/*COMPLICATIONS/DIAGNOSIS Male Polymerase Chain
Reaction Saliva/*VIROLOGY Support, Non-U.S. Gov't CLINICAL TRIAL
JOURNAL ARTICLE RANDOMIZED CONTROLLED TRIAL
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).